Chronic hepatitis C infection and sicca syndrome: A clear association with HLA DQB1*02

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 6, 2007, Pages 493-498

  Smyth, Claire M ^a   McKiernan, Susan M ^a   Hagan, Richard ^a   Pilkington, Ruth ^a   O'Regan, Myra ^b   Lawlor, Emer ^a   Kelleher, Dermot ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hepatitis C virus; Human leukocyte antigen DQB1*02; Sicca syndrome

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN;

ADULT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SYMPTOM; VIRUS STRAIN;

FEMALE; HEPATITIS C, CHRONIC; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; VIRAL LOAD;

EID: 34248156262     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328010687d     Document Type: Review

References (36)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.
2. Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. Gastroenterology 1994; 106:1118-1120.
3. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19:841-848.
4. Pivetti S, Novarino A, Merico F, Bertero MT, Brunetto MR, Bonino F, Caligaris-Cappio F. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol 1996; 95:204-211.
5. Agnello V. Hepatitis C virus infection type II cryoglobulinemia: an immunological perspective. Hepatology 1997; 26:1375-1379.
6. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996; 24:1338-1341.
7. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123:615-620.
8. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21:613-619.
9. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122:169-173.
10. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin Irish Hepatology Research Group. N Engl J Med 1999; 340:1228-1233.
11. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996; 55:116-121.
12. Brun JG, Madland TM, Jonsson R. A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Rheum 2003; 49:187-192.
13. Setty YN, Pittman CB, Mahale AS, Greidinger EL, Hoffman RW. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease. J Rheumatol 2002; 29:487-489.
14. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J. Sjogren's syndrome and hepatitis C virus. Clin Rheumatol 1999; 18:93-100.
15. Garcia-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Munoz FJ, et al. Hepatitis C virus infection in 'primary' Sjogren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56:173-175.
16. Rodriguez-Cuartero A, Garcia-Vera E, Gomez-Cerro A. Hepatitis C virus and Sjogren's syndrome. Infection 1994; 22:415-416.
17. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339:321-323.
18. McKiernan SM, Hagan R, Curry M, McDonald GS, Nolan N, Crowley J, et al. The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology 2000; 118:1124-1130.
19. Reveille JD. The molecular genetics of systemic lupus erythematosus and Sjogrens syndrome. Curr Opin Rheumatol 1992; 4:644-656.
20. Avoustin PA, Tkaczuk J, Coppin HL, Cambon-Thomsen A, de Preval C. Extended HLA-DQw2 alleles: molecular analysis. Eur J Immunogenet 1991; 18:247-257.
21. McManus R, Moloney M, Borton M, Finch A, Chuan YT, Lawlor E, et al. Association of celiac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum Immunol 1996; 45:24-31.
22. Savage DA, Middleton D, Trainor F, Taylor A, Carson M, Stevens FM, McCarthy CF. HLA class II frequencies in celiac disease patients in the west of Ireland. Hum Immunol 1992; 34:47-52.
23. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39:1166-1171.
24. Marsh SGE, Parham P, Barber LD. The HLA facts book. New York: Academic Press; 2000.
25. Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Manthorpe R, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245:127-132.
26. Nepom GT. MHC and autoimmune diseases. Immunol Ser 1993; 59:143-164.
27. Merriman TR, Todd JA. Genetics of autoimmune disease. Curr Opin Immunol 1995; 7:786-792.
28. Tomlinson IP, Bodmer WF. The HLA system and the analysis of multifactorial genetic disease. Trends Genet 1995; 11:493-498.
29. Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum Immunol 2001; 62:725-731.
30. Garcia Portales R, Belmonte Lope MA, Camps Garcia MT, Ocon Sanchez P, Alonso Ortiz A, Guil Garcia M, de Ramon Garrido E. Immunogenetics of the Sjogren's syndrome in southern Spain. Ann Med Int 1994; 11:56-61.
31. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 1986; 232:1145-1147.
32. Davies ML, Taylor EJ, Gordon C, Young SP, Welsh K, Bunce M, et al. Candidate T cell epitopes of the human La/SSB autoantigen. Arthritis Rheum 2002; 46:209-214.
33. Nakken B, Jonsson R, Brokstad KA, Omholt K, Nerland AH, Haga HJ, Halse AK. Associations of MHC class II alleles in Norwegian primary Sjogren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 2001; 54:428-433.
34. Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Columbian patients with primary Sjogren's syndrome. Semin Arthritis Rheum 2002; 31:396-405.
35. Hadj Kacem H, Kaddour N, Adyel F-Z, Bahloul Z. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology 2001; 40:1370-1374.
36. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids. Hepatology 1996; 24:1342-1345.